Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celgene

Celgene
1986 FOUNDED
M&A STATUS
5K-10K EMPLOYEES
M&A LATEST DEAL TYPE
$74B LATEST DEAL AMOUNT
Description

Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma drug Istodax, and cancer drug Abraxane. The firm's first immunology drug, Otezla, was approved in the U.S. in 2014. Recent acquisitions of Juno and Impact bring additional drugs for Celgene's blood cancer pipeline.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Primary Office
  • 86 Morris Avenue
  • Summit, NJ 07901
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celgene’s full profile, request a free trial.

Celgene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 20-Nov-2019 $74B 000.00 0000 Completed Profitable
3. PIPE 000.00 Completed Profitable
2. IPO 28-Jul-1987 $12.7M $12.7M Completed Generating Revenue
1. Early Stage VC 01-Jan-1986 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Celgene Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regeneron Pharmaceuticals Formerly VC-backed Tarrytown, NY 0000 00000 000000000 00 00000
000000000 Formerly VC-backed Exton, PA 000 0000 000000&0 0000
000000 Formerly VC-backed Cambridge, MA 0000 000.00 00000000000 000.00
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
00000 & 00. Corporation Kenilworth, NJ 00000
To view this company’s complete list of competitors, request access »

Celgene Investments & Acquisitions (125)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 20-Dec-2019 00000 00000 00 000.00 Therapeutic Devices
000000 00000000000 15-Oct-2019 00000 00000 00 000.00 Biotechnology 00000 000000000
0000000 11-Sep-2019 00000 00000 00 0000 Drug Discovery
0000 000000000000 18-Jun-2019 00000 00000 00 0000 Drug Discovery
Cleave Therapeutics 17-Jun-2019 Later Stage VC 0000 Pharmaceuticals
To view this company’s complete investment and acquisition history, request access »

Celgene Exits (41)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000000000 18-Jun-2019 00000 00000 00 0000 Completed
  • 6 buyers
00000 000000000 26-Jul-2018 00000 00000 00 000.00 Completed
  • 13 buyers
0000 000000000000 01-Apr-2018 00000 00000 00 0000 Completed
  • 5 buyers
00000 00000000000 23-Mar-2018 00000 00000 00 000.00 Completed
  • 8 buyers
Arcus Biosciences 03-Nov-2017 Later Stage VC 00000 Completed
  • 13 buyers
To view this company’s complete exits history, request access »

Celgene Subsidiaries (5)

Company Name Industry Location Founded
EngMab Biotechnology Pfaffikon, Switzerland 2013
000000000 00000000 Therapeutic Devices San Francisco, CA 0000
00000000 000000000 Drug Discovery Boston, MA 0000
00000 000000000000 Biotechnology Watertown, MA 0000
0000000000000 Diagnostic Equipment Rockville, MD 0000
To view this company’s complete subsidiary history, request access »

Celgene Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Asseily Ventures Venture Capital Minority 000 0000 000000 0
BB Biotech Asset Manager Minority 000 0000 000000 0
CHL Medical Partners Venture Capital Minority 000 0000 000000 0
Edelson Technology Partners Venture Capital Minority 000 0000 000000 0

Celgene Executive Team (62)

Name Title Board
Seat
Contact
Info
Robert Hugin Chief Executive Officer & Chairman
Anne Bucci Senior Executive Administrative Assistant
Björn Hellström Nordic Director CAR T
John Chardonnens TitleDirector, IT Site Lead and Business Partner
Maria Palmisano Executive

43 Former Executives

You’re viewing 5 of 62 executives. Get the full list »

Celgene Board Members (28)

Name Representing Role Since Contact
Info
Carrie Cox Self Board Member 000 0000
Ernest Mario Ph.D Self Board Member 000 0000
Gilla Kaplan Self Board Member 000 0000
Hans Bishop Self Board Member 000 0000
James Loughlin Self Board Member 000 0000

14 Former Board Members

You’re viewing 5 of 28 board members. Get the full list »